The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

Share Price Information for Alpha Growth (ALGW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.80
Bid: 1.70
Ask: 1.90
Change: 0.00 (0.00%)
Spread: 0.20 (11.765%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.80
ALGW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Colva

1 Mar 2019 07:00

RNS Number : 5169R
Alpha Growth PLC
01 March 2019
 

1 March 2019

Alpha Growth plc

("Alpha", or the "Company")

 

Acquisition of Colva

 

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class, is pleased to announce the acquisition of Colva Insurance Services Corp. ("Colva").

The Company has signed an agreement for the acquisition of the entire ordinary share capital of Colva. Colva is a specialist actuarial service provider to the SLS industry and has a number of key clients, primarily based in the US.

The major shareholder of Colva is Rajiv Rebello, who founded Colva in order to use his first hand actuarial and life insurance expertise to minimize premium payments and maximize returns for life insurance and life settlement investors. Rajiv is a Fellow of the Society of Actuaries (FSA) and prior to Colva worked on AIG's 4,000+ policy life settlement portfolio with $18 billion in face. Prior to AIG, Rajiv worked at New York Life helping to price, design and create illustration software for their Universal Life and Variable Universal Life products. While at New York Life, Rajiv was also involved in analyzing mortality and lapse data experience and the creation of a new mortality table for New York Life. Colva is incorporated in California, USA, company number 3404971.

Alpha will acquire the entire share capital of Colva for a total consideration of £77,727 which shall be settled through the issue of 3,985,985 new ordinary shares of 0.1 pence each in the Company at an issue price of 1.95p per share, being the closing price of Alpha's shares on the day heads of terms were agreed. The shares will be issued and admitted for trading on the one year anniversary of the acquisition, subject to Rajiv continuing to be commercially engaged with Alpha on the issue date.

Further announcements will be made in due course.

 

Gobind Sahney, Chairman commented:

"The acquisition of Colva includes the addition of Rajiv who will become our Chief Actuary and Director of Investment Analytics. Rajiv is a terrific addition to the team and expands our in-house abilities to provide clients with superior advise and guidance on longevity assets. We welcome Rajiv and the clients that Colva works with to the Alpha team."

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

info@algwplc.com

 

 

Vox Markets (Digital IR)

+44 (0) 203 865 0130

Abraham Darwyne

content@voxmarkets.co.uk

 

 

Novum Securities Limited (Corporate Broker)

+44 (0) 207 399 9400

Colin Rowbury

crowbury@novumsecurities.com

 

About Alpha Growth plcSpecialist in Longevity AssetsAlpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, Alpha Growth has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Company's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQDBGDDDGDBGCI
Date   Source Headline
10th Feb 20208:00 amRNSResult of AGM
31st Dec 20197:00 amRNSPublication of the 2019 Annual Report
17th Dec 20197:00 amRNSTrack Record Review, Placing & Total Voting Rights
2nd Dec 20197:00 amRNSAdvancement of Warehousing SPV and Subscription
11th Nov 20197:00 amRNSAppointments and Board changes
20th Sep 201911:46 amRNSSecond Price Monitoring Extn
20th Sep 201911:45 amRNSPrice Monitoring Extension
18th Sep 20193:31 pmRNSAlpha Growth - Holding(s) in Company
12th Aug 20197:00 amRNSHolding(s) in Company
15th Jul 20197:00 amRNSCorporate Update
2nd Jul 20199:14 amRNSHolding(s) in Company
5th Jun 20197:00 amRNSIssue of Equity & TVR
16th May 201912:00 pmRNSHolding(s) in Company
10th May 20192:16 pmRNSPublication of Prospectus
3rd May 201911:05 amRNSSecond Price Monitoring Extn
3rd May 201911:00 amRNSPrice Monitoring Extension
30th Apr 20197:20 amRNSProposed Placing
30th Apr 20197:00 amRNSBlackOak Alpha Growth Fund Launch
29th Apr 20194:00 pmRNSInterim Results
18th Apr 20192:00 pmRNSPrice Monitoring Extension
29th Mar 20192:28 pmRNSHolding(s) in Company
6th Mar 20197:00 amRNSBoard Changes
4th Mar 201910:10 amRNSResult of AGM
4th Mar 20197:00 amRNSCorporate Update
1st Mar 20197:00 amRNSAcquisition of Colva
20th Feb 201910:28 amRNSIssue of Equity
13th Feb 20197:00 amRNSAlpha Growth Investor Meeting
7th Feb 20197:00 amRNSAlpha Growth - Notice of Annual General Meeting
30th Jan 20197:00 amRNSAcquisition: Completion of ALM Acquisition
24th Dec 201810:52 amRNSFinal Results
21st Nov 20187:00 amRNSSL Investment Management Joint Venture
15th Nov 201811:36 amRNSHolding(s) in Company
24th Sep 20181:59 pmRNSHolding(s) in Company
17th Sep 20184:40 pmRNSSecond Price Monitoring Extn
17th Sep 20184:35 pmRNSPrice Monitoring Extension
17th Sep 20182:05 pmRNSSecond Price Monitoring Extn
17th Sep 20182:00 pmRNSPrice Monitoring Extension
17th Sep 201812:18 pmRNSHolding(s) in Company
17th Sep 20187:00 amRNSIssue of Equity and Director/PDMR Dealing
4th Sep 20185:14 pmRNSHolding(s) in Company
30th Aug 201812:16 pmRNSHolding(s) in Company
24th Aug 201812:59 pmRNSNotification of Major Holdings
18th Jul 20187:00 amRNSAcquisition of ALM
13th Jun 20187:00 amRNSHolding(s) in Company
8th Jun 20187:00 amRNSEngagement of Devonshire Warwick, Investor Event
1st Jun 20187:00 amRNSAppointment of Chief Operating Officer
11th May 20184:03 pmRNSHolding(s) in Company
30th Apr 20181:00 pmRNSInterim results
12th Mar 20182:13 pmRNSAppointment of Corporate Advisor and Broker
6th Feb 20187:00 amRNSLaunch of Innovative Hybrid Product

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.